Refine
Departments, institutes and facilities
- Institut für funktionale Gen-Analytik (IFGA) (422) (remove)
Document Type
- Article (422) (remove)
Year of publication
Has Fulltext
- no (422) (remove)
Keywords
- ENaC (10)
- apoptosis (6)
- CD21 (4)
- DNA methylation (4)
- 5-Methylcytosine (3)
- Amiloride (3)
- Arthritis (3)
- Bcl-2 (3)
- Na+/K+-ATPase (3)
- cancer (3)
- shedding (3)
- B cell activation (2)
- Canavan disease (2)
- Capillary electrophoresis – laser-induced fluorescence (2)
- Chronic lymphocytic leukemia (2)
- Complement receptor (2)
- Complement receptor 2/CD21 (2)
- DNA adducts (2)
- Enzyme activity (2)
- Epithelial Na+ channel (2)
- Epithelial sodium channel (2)
- Fatty acid metabolism (2)
- GLYCTK (2)
- H2S (2)
- Inborn error of metabolism (2)
- K/BxN (2)
- Ketoacidosis (2)
- Ketolysis (2)
- Ketone body utilization (2)
- Mast cells (2)
- Movement disorder (2)
- NF-κB (2)
- Organic aciduria (2)
- Rheumatoid arthritis (2)
- Shedding (2)
- acetylcholine (2)
- cystic fibrosis (2)
- cytokine-induced killer cells (2)
- d-Glycerate kinase deficiency (2)
- d-Glyceric aciduria (2)
- delta-subunit (2)
- endocytosis (2)
- epithelial sodium channel (ENaC) (2)
- evolution (2)
- gasotransmitter (2)
- hydrogen sulfide (2)
- mucociliary clearance (2)
- sodium channel (2)
- sodium transport (2)
- transgenic mice (2)
- water-to-land transition (2)
- 3-hydroxyisobutyrate dehydrogenase (1)
- 3-hydroxyisobutyric acid dehydrogenase deficiency (1)
- 3-hydroxyisobutyric aciduria (1)
- 5-HT (1)
- 5-Oxoprolinase (1)
- 5-oxoprolinuria (1)
- ADA2 (1)
- AMT (1)
- ASIC (1)
- ASPA (1)
- Acute lymphoblastic leukemia (1)
- Acylpeptide hydrolase (1)
- Airway surface liquid (1)
- Alkane (1)
- Allicin (1)
- Amino Acid Sequence (1)
- Aminoacylase (1)
- Aminoacylase 1 (1)
- Amylose stationary phases (1)
- Anionic surfactant (1)
- Ankle thickness (1)
- Antiphospholipid syndrome (APS) (1)
- Apheresis therapy (1)
- Aspartoacylase (1)
- Autism (1)
- Autoantibody (1)
- Automated multiple development (1)
- B cells (1)
- B lymphocyte (1)
- B-cell lymphoma (1)
- BAD (1)
- Background music (1)
- Bactericidal effect (1)
- Basis set (1)
- Behcet’s Disease (1)
- Benzyl alkyl ammonium chloride (1)
- Beta-ketothiolase deficiency (1)
- Biomarkers stability (1)
- Biosignatures (1)
- Biotin (1)
- Block copolymer (1)
- Breast (1)
- CD146 (1)
- CD40 (1)
- CE-LIF (1)
- CFTR (1)
- CHRNA (1)
- CIBERSORT (1)
- CLL (1)
- CO (1)
- CR2 (1)
- CREBBP (1)
- Capillary electrophoresis (1)
- Carbapenem (1)
- Carboxy-terminal fragments (1)
- Caspase (1)
- Cationic surfactant (1)
- Cell activation (1)
- Cellulose stationary phases (1)
- Ceramides (1)
- Chalcogenide glass sensor (1)
- Chiral stationary phases (1)
- Cholesterol (1)
- Cognition (1)
- Collision induced dissociation (1)
- Color/Spot-Test (1)
- Complement (1)
- Complement receptor 2 (1)
- Complement receptor 2 /CD21 (1)
- Comprehensive two-dimensional liquid chromatography (1)
- Confocal microscopy (1)
- Cross-sensitivity (1)
- Cytochrome c (1)
- Cytokine (1)
- Cytokine-induced killer (CIK) cells (1)
- DADA2 (1)
- DEG/ENaC family (1)
- DIDMOAD (1)
- DNA (1)
- DNA typing (1)
- Daptomycin (1)
- Databases, Factual (1)
- Deficiency of ADA2 (1)
- Degraded DNA (1)
- Dehydrogenase (1)
- Delta-ENaC (1)
- Diaminphenylderivat (1)
- Diselenide bridge (1)
- Drug resistance (1)
- Dystonia (1)
- EPHB2 (1)
- Ectodomain shedding (1)
- Electronic tongue (1)
- Enantioselective gas chromatography (1)
- Endoplasmatic reticulum (1)
- Endothelial cells (1)
- Epigenomics (1)
- Epilepsy (1)
- Epithelial-mesenchymal transition (1)
- Esterquat (1)
- Evans blue (1)
- Ewing´s Sarcoma Family of Tumors (1)
- ExoMars (1)
- Exome sequencing (1)
- FGR (1)
- FOXA1 (1)
- FOXP3 (1)
- Fatty acids (1)
- Fatty alcohol alkoxylate (1)
- Fatty alcohol alkoxylates (1)
- Fibroblast-like synoviocytes (FLS) (1)
- Food allergy (1)
- Forensic genomics (1)
- Forkhead (1)
- Fructose (1)
- Fuzzy logic (1)
- GC × GC (1)
- GC×GC (1)
- GSK-3b (1)
- Garlic (1)
- Gesamt-Exom-Sequenzierung (1)
- Glutathione (1)
- Glutathione synthetase (1)
- Glycerate (1)
- Glyceric aciduria (1)
- Glycine N-Acyltransferase (GLYAT) (1)
- Glycine conjugation (1)
- Glycopeptides (1)
- HDAC inhibitor (1)
- HIBADH (1)
- HIBADH deficiency (1)
- HIF1α (1)
- HILIC (1)
- HPTLC (1)
- HSD10 (1)
- Health care policy (1)
- High hyperdiploidy (1)
- High performance liquid chromatography (1)
- Histamine (1)
- Histamine receptors (1)
- Hydrophobic interaction (1)
- Hydrophobicity (1)
- Hyperammonemia (1)
- Ikaros (1)
- Immunoadsorption (1)
- Inborn errors of metabolism (1)
- Inherited metabolic disorders (1)
- Intellectual disability (1)
- Interactive computer graphics (1)
- Intracellular Ca2+ (1)
- Involution (1)
- Ion mobility (1)
- Ionizing radiation (1)
- Isoleucine degradation (1)
- Isovaleric acidemia (1)
- Juvenile arthritis (JA) (1)
- K/BxN mouse model (1)
- K/B×N model (1)
- Ketoasidoz (1)
- Ketogenesis (1)
- Ketone body synthesis (1)
- Kozak-sequence (1)
- Kriminaltechnik (1)
- LCxLC-MS (1)
- LEF1 (1)
- Laser-induced fluorescence (1)
- Leucine degradation (1)
- Linezolid (1)
- Lipophilicity (1)
- Lipophilicity potential (1)
- Locomotion (1)
- Lysosome (1)
- MALDI QIT TOF MS (1)
- MCF-10A (1)
- MOCS1 (1)
- MP2.5 (1)
- MRPP (1)
- MS/MS peptide sequencing (1)
- MYB (1)
- Macrophage (1)
- Macrophage migration inhibitory factor (1)
- Macrophages (1)
- Mammary (1)
- Marbled crayfish (1)
- Mars (1)
- Mars exploration (1)
- Matrix metalloproteases (1)
- Mechanosensitive (1)
- Media in education (1)
- Memory (1)
- Metabolic acidosis (1)
- Metabolic stroke (-like event) (1)
- Metabolicdecompensation (1)
- Methylation (1)
- Methylmalonic acidemia (1)
- Methylmalonic aciduria (1)
- Methylmalonyl-CoAmutase (1)
- Methyltransferase (1)
- Micromanipulation (1)
- Mitochondrial tRNA (1)
- Moco deficiency (1)
- Molecular Sequence Data (1)
- Molecular modelling (1)
- Molecular surface (1)
- Molybdenum cofactor (1)
- Motion tracking (1)
- Multi-component heavy metal solution (1)
- N-acetylaspartic acid (1)
- N-acylated amino acids (1)
- NO (1)
- Na+ absorption (1)
- Na+/K+ ATPase (1)
- Native mass spectrometry (1)
- Neugeborenenscreening (1)
- Neuropilin (1)
- Next Generation Sequencing (NGS) (1)
- Next generation sequencing (1)
- Nitrogruppe (1)
- Nonketotic hyperglycinemia (1)
- OXCT1 (1)
- Organic acids (1)
- Organische Säuren (1)
- Oxidative stress (1)
- PK-B/Akt (1)
- Partition coefficients (1)
- Pervanadate (1)
- Pharmacogenetics (1)
- Phase II reaction (1)
- Polymorphism (1)
- Pregnancy (1)
- Probabilistic methods (1)
- Programmed cell death (1)
- Propionic acidemia (1)
- Propionic aciduria (1)
- Propionyl-CoA carboxylase (1)
- Proteasome (1)
- Proteasome maturation (1)
- Protein Conformation (1)
- Protein Folding (1)
- Protein-protein interaction (1)
- Proteins/chemistry (1)
- Pulmonary epithelium (1)
- Pyroglutamic aciduria (1)
- Quasi equilibrium conditions (1)
- RAID (1)
- RAS (1)
- RELA (1)
- RELA haploinsufficiency (1)
- RELA-associated inflammatory disease (1)
- Raman and FTIR spectroscopies (1)
- Random copolymer (1)
- Redox potential (1)
- Relapse (1)
- RhoA GTPases (1)
- S-sulfocysteine (1)
- SAHA (1)
- SARS-COV-2 virus (1)
- SOS-LC (1)
- Schmauchspur (1)
- Schusswaffe (1)
- Seizures (1)
- Selektives Screening (1)
- Selenocysteine (1)
- Sequence Homology, Amino Acid (1)
- Serine (1)
- Sexual assault (1)
- Shear force (1)
- Short tandem repeat (STR) (1)
- Single sperm cells (1)
- Soluble CD21 (1)
- Soluble CD23 (1)
- Splicing (1)
- Stratum corneum lipids (1)
- Submucosal plexus (1)
- Sulfite oxidase (1)
- Surfactants (1)
- Survey (1)
- Synovial fluid (1)
- Systemic lupus erythomatosus (SLE) (1)
- TNF inhibitors (1)
- TP53 (1)
- Tandem-Massenspektrometrie (1)
- Telemedicine (1)
- Telogen hair (1)
- Tetramerisation (1)
- Thiol antioxidants (1)
- Time–kill methodology (1)
- Transcriptional enhancer (1)
- Transgenic mice (1)
- Triangle mesh (1)
- Urea cycle defect (1)
- Urine organic acid analysis (1)
- Urothione (1)
- Valproic acid (1)
- Vascular permeability (1)
- Virtual Environment (1)
- Virtual Memory Palace (1)
- Virtual reality (1)
- Vitamin A acetate isomers (1)
- Vitamin B12/adenosylcobalamin (1)
- Whole genome amplification (1)
- Wnt/β-catenin (1)
- Wolframin (1)
- Xenopus (1)
- Xenopus laevis (1)
- Xenopus oocyte (1)
- Yersinia toxins (1)
- ZAP-70 (1)
- acute (1)
- acute respiratory distress syndrome (1)
- adoptive cell transfer (1)
- air-blood barrier (1)
- airway (1)
- airway rehydration (1)
- airway smooth muscle (1)
- albuminuria (1)
- alkaline phosphatase (1)
- allopurinol (1)
- allosteric regulation (1)
- alveolar epithelium (1)
- alveolar fluid (1)
- alveolar fluid transport (1)
- alveoli (1)
- amino acid transport (1)
- anorganische Schmauchspur (1)
- anti-TNF (1)
- arthritis (1)
- atopy (1)
- autoimmune disease (1)
- autoimmunity (1)
- autoinflammation (1)
- autoinflammatory (1)
- autoinflammatory diseases (1)
- automatic segmentation (1)
- biochemistry (1)
- bone marrow failure (1)
- brain tumor (1)
- breathing (1)
- bronchus (1)
- brush cells (1)
- cPMP (1)
- cancer progression (1)
- carbon monoxide (1)
- carbon monoxide-releasing molecule (1)
- caspase-3 (1)
- caspases (1)
- caveolin-1 (1)
- cell death (1)
- chemical pathology (1)
- chemosensory cells (1)
- childhood (1)
- childhood cancer syndrome (1)
- cholinergic (1)
- chromatin remodeling (1)
- chymotrypsin (1)
- ciclopirox olamine (1)
- common variable immunodeficiency (1)
- complete basis set limit (1)
- constitutional mismatch repair syndrome (1)
- contraction (1)
- cyanide (1)
- cytokine-induced killer (CIK) cells (1)
- deficiency of adenosine deaminase 2 (1)
- dynamin (1)
- electrochemical sensor (1)
- electrolyte transport (1)
- electrophysiology (1)
- electroretinography (1)
- electrostatic potential (1)
- epilepsy (1)
- epithelial sodium channels (1)
- epithelial transport (1)
- erbliche Krebssyndrome (1)
- ethacrynic acid (1)
- extra column band broadening (1)
- familial Mediterranean fever (1)
- fish gill (1)
- flow cytometry (1)
- four-ply (1)
- fuel (1)
- furin (1)
- fuzzy logic (1)
- gas exchange (1)
- genes (1)
- genetic testing (1)
- genetics (1)
- genetische Testung (1)
- genome sequencing (1)
- genotype-phenotype correlations (1)
- glycerol (1)
- glycerophosphocholine (1)
- growth hormone (1)
- heat shock proteins (1)
- heat shock response (1)
- heavy metal (1)
- hematopoietic stem cell transplantation (1)
- hepatocellular carcinoma (1)
- heterozygous ALPL mutation (1)
- high-performance liquid chromatography (1)
- histamine receptor (1)
- histamine receptor antagonist (1)
- histidine decarboxylase (1)
- hydrocarbon (1)
- hypogammaglobulinemia (1)
- hypophosphatasia (1)
- hypoxia (1)
- immunhistochemistry (1)
- immunodeficiency (1)
- immunology (1)
- immunotherapy (1)
- inflammasome (1)
- inhibitor (1)
- inorganic pyrophosphate (1)
- insertion (1)
- interferon γ (1)
- interleukin-1beta (1)
- intrinsic pathway (1)
- ion-selective electrodes (1)
- isoleucine metabolism (1)
- ketogenesis defects (1)
- ketogenez defektleri (1)
- ketoliz defektleri (1)
- ketolysis (1)
- ketolysis defects (1)
- keton bodies (1)
- leukemia (1)
- life-detection (1)
- lipid (1)
- liquid chromatography (1)
- local lipophilicity (1)
- loss-of-function variants (1)
- lung (1)
- lung cancer (1)
- lung liquid clearance (1)
- lymphocytic (1)
- lysophosphatidylcholine (1)
- mTOR (1)
- macrophages. (1)
- major histocompatibility complex class I polypeptide-related sequence A (MICA) (1)
- mammary gland (1)
- member D (NKG2D) (1)
- metabolic acidosis (1)
- metabolic effects (1)
- metabolic integration (1)
- microcephaly (1)
- microdialysis (1)
- mitosis (1)
- mixed-mode chromatography (1)
- molecular evolution (1)
- molecular surfaces (1)
- mouse model (1)
- mp2 (1)
- mucosal ulcers (1)
- multiple myeloma (MM) (1)
- muscarine (1)
- mutation (1)
- natural killer group 2 (1)
- nicotine and phosphocholine (1)
- nitric oxide (1)
- nucleic acids (1)
- octane (1)
- organische Schmauchspur (1)
- outside-out (1)
- pH (1)
- paediatric clinical genetics & dysmorphology (1)
- paediatric endocrinology (1)
- paediatric intensive & critical care (1)
- patch clamp (1)
- patch-clamp (1)
- pharmacokinetics (1)
- phenylketonuria (1)
- phosphoethanolamine (1)
- pigments (1)
- porphyria (1)
- propan-2-ol (1)
- protease (1)
- proteomics (1)
- proximal tubule (1)
- pure red cell aplasia (1)
- pyridoxal phosphate (1)
- pyrin inflammasome (1)
- quantum mechanics (1)
- recurrent ketoacidotic episodes (1)
- retinal degeneration (1)
- rheumatoid arthritis (1)
- sCD21 (1)
- sFRP-4 (1)
- salt (1)
- screening (1)
- selectivity tuning (1)
- sensitize (1)
- serine-threonine kinase (1)
- serum and glucocorticoid-induced kinase 1 (1)
- single-cell RNA-seq (1)
- skin cancer (1)
- sodium absorption (1)
- sodium self-inhibition (1)
- sodium/potassium-exchanging ATPase (1)
- stationary phase (1)
- superficially porous particles (1)
- surface shape (1)
- surface topology (1)
- symbiosis (1)
- system optimization (1)
- tRNA processing (1)
- taste (1)
- temporomandibular joint (1)
- tetrapod (1)
- three-ply (1)
- tiglyglycine (1)
- transporter (1)
- tumor microenvironment (1)
- tumor-infiltrating immune cells (1)
- ubiquitination (1)
- urethra (1)
- urethral brush cells (1)
- valine catabolic pathway (1)
- van Deemter curve (1)
- vasculitis (1)
- voltage-independent Na+ channel (1)
- water dimer (1)
- whole-exome sequencing (1)
- µCT (1)
- β-cells (1)
- γ-glutamyl cycle (1)
Striated muscle contraction is regulated by the translocation of troponin-tropomyosin strands over the thin filament surface. Relaxation relies partly on highly-favorable, conformation-dependent electrostatic contacts between actin and tropomyosin, which position tropomyosin such that it impedes actomyosin associations. Impaired relaxation and hypercontractile properties are hallmarks of various muscle disorders. The α-cardiac actin M305L hypertrophic cardiomyopathy-causing mutation lies near residues that help confine tropomyosin to an inhibitory position along thin filaments. Here, we investigate M305L actin in vivo, in vitro, and in silico to resolve emergent pathological properties and disease mechanisms. Our data suggest the mutation reduces actin flexibility and distorts the actin-tropomyosin electrostatic energy landscape that, in muscle, result in aberrant contractile inhibition and excessive force. Thus, actin flexibility may be required to establish and maintain interfacial contacts with tropomyosin as well as facilitate its movement over distinct actin surface features and is, therefore, likely necessary for proper regulation of contraction.
RELA haploinsufficiency is a recently described autoinflammatory condition presenting with intermittent fevers and mucocutaneous ulcerations. The RELA gene encodes the p65 protein, one of five NF-κB family transcription factors. As RELA is an essential regulator of mucosal homeostasis, haploinsufficiency leads to decreased NF-κB signaling which promotes TNF-driven mucosal apoptosis with impaired epithelial recovery. Thus far, only eight cases have been reported in the literature. Here, we report four families with three novel and one previously described pathogenic variant in RELA. These four families included 23 affected individuals for which genetic testing was available in 16. Almost half of these patients had been previously diagnosed with more common rheumatologic entities (such as Behcet's Disease; BD) prior to the discovery of their pathogenic RELA variants. The most common clinical features were orogenital ulcers, rash, joint inflammation, and fever. The least common were conjunctivitis and recurrent infections. Clinical variability was remarkable even among familial cases, and incomplete penetrance was observed. Patients in our series were treated with a variety of medications, and benefit was observed with glucocorticoids, colchicine, and TNF inhibitors. Altogether, our work adds to the current literature and doubles the number of reported cases with RELA-Associated Inflammatory Disease (RAID). It reaffirms the central importance of the NF-κB pathway in immunity and inflammation, as well as the important regulatory role of RELA in mucosal homeostasis. RELA associated inflammatory disease should be considered in all patients with BD, particularly those with early onset and/or with a strong family history.
The deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessively inherited disease that has undergone extensive phenotypic expansion since being first described in patients with fevers, recurrent strokes, livedo racemosa, and polyarteritis nodosa in 2014. It is now recognized that patients may develop multisystem disease that spans multiple medical subspecialties. Here, we describe the findings from a large single center longitudinal cohort of 60 patients, the broad phenotypic presentation, as well as highlight the cohort's experience with hematopoietic cell transplantation and COVID-19. Disease manifestations could be separated into three major phenotypes: inflammatory/vascular, immune dysregulatory, and hematologic, however, most patients presented with significant overlap between these three phenotype groups. The cardinal features of the inflammatory/vascular group included cutaneous manifestations and stroke. Evidence of immune dysregulation was commonly observed, including hypogammaglobulinemia, absent to low class-switched memory B cells, and inadequate response to vaccination. Despite these findings, infectious complications were exceedingly rare in this cohort. Hematologic findings including pure red cell aplasia (PRCA), immune-mediated neutropenia, and pancytopenia were observed in half of patients. We significantly extended our experience using anti-TNF agents, with no strokes observed in 2026 patient months on TNF inhibitors. Meanwhile, hematologic and immune features had a more varied response to anti-TNF therapy. Six patients received a total of 10 allogeneic hematopoietic cell transplant (HCT) procedures, with secondary graft failure necessitating repeat HCTs in three patients, as well as unplanned donor cell infusions to avoid graft rejection. All transplanted patients had been on anti-TNF agents prior to HCT and received varying degrees of reduced-intensity or non-myeloablative conditioning. All transplanted patients are still alive and have discontinued anti-TNF therapy. The long-term follow up afforded by this large single-center study underscores the clinical heterogeneity of DADA2 and the potential for phenotypes to evolve in any individual patient.
Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS
(2021)
BACKGROUND
Biallelic loss-of-function variants in NCF1 lead to reactive oxygen species deficiency and chronic granulomatous disease (CGD). Heterozygosity for the p.Arg90His variant in NCF1 has been associated with susceptibility to systemic lupus erythematosus, rheumatoid arthritis, and Sjögren's syndrome in adult patients. This study demonstrates the association of the homozygous p.Arg90His variant with interferonopathy with features of autoinflammation and autoimmunity in a pediatric patient.
CASE PRESENTATION
A 5-year old female of Indian ancestry with early-onset recurrent fever and headache, and persistently elevated antinuclear, anti-Ro, and anti-La antibodies was found to carry the homozygous p.Arg90His variant in NCF1 through exome sequencing. Her unaffected parents and three other siblings were carriers for the mutant allele. Because the presence of two NCF1 pseudogenes, this variant was confirmed by independent genotyping methods. Her intracellular neutrophil oxidative burst and NCF1 expression levels were normal, and no clinical features of CGD were apparent. Gene expression analysis in peripheral blood detected an interferon gene expression signature, which was further supported by cytokine analyses of supernatants of cultured patient's cells. These findings suggested that her inflammatory disease is at least in part mediated by type I interferons. While her fever episodes responded well to systemic steroids, treatment with the JAK inhibitor tofacitinib resulted in decreased serum ferritin levels and reduced frequency of fevers.
CONCLUSION
Homozygosity for p.Arg90His in NCF1 should be considered contributory in young patients with an atypical systemic inflammatory antecedent phenotype that may evolve into autoimmunity later in life. The complex genomic organization of NCF1 poses a difficulty for high-throughput genotyping techniques and variants in this gene should be carefully evaluated when using the next generation and Sanger sequencing technologies. The p.Arg90His variant is found at a variable allele frequency in different populations, and is higher in people of South East Asian ancestry. In complex genetic diseases such as SLE, other rare and common susceptibility alleles might be necessary for the full disease expressivity.
Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies (NEDDFL), defined primarily by developmental delay/intellectual disability, speech delay, postnatal microcephaly, and dysmorphic features, is a syndrome resulting from heterozygous variants in the dosage-sensitive bromodomain PHD finger chromatin remodeler transcription factor BPTF gene. To date, only 11 individuals with NEDDFL due to de novo BPTF variants have been described. To expand the NEDDFL phenotypic spectrum, we describe the clinical features in 25 novel individuals with 20 distinct, clinically relevant variants in BPTF, including four individuals with inherited changes in BPTF. In addition to the previously described features, individuals in this cohort exhibited mild brain abnormalities, seizures, scoliosis, and a variety of ophthalmologic complications. These results further support the broad and multi-faceted complications due to haploinsufficiency of BPTF.
Mendelian diseases of dysregulated canonical NF-κB signaling: From immunodeficiency to inflammation
(2020)
Systemic autoinflammatory diseases (SAIDs) are a group of inflammatory disorders caused by dysregulation in the innate immune system that leads to enhanced immune responses. The clinical diagnosis of SAIDs can be difficult since individually these are rare diseases with considerable phenotypic overlap. Most SAIDs have a strong genetic background, but environmental and epigenetic influences can modulate the clinical phenotype. Molecular diagnosis has become essential for confirmation of clinical diagnosis. To date there are over 30 genes and a variety of modes of inheritance that have been associated with monogenic SAIDs. Mutations in the same gene can lead to very distinct phenotypes and can have different inheritance patterns. In addition, somatic mutations have been reported in several of these conditions. New genetic testing methods and databases are being developed to facilitate the molecular diagnosis of SAIDs, which is of major importance for treatment, prognosis and genetic counselling. The aim of this review is to summarize the latest advances in genetic testing for SAIDs and discuss potential obstacles that might arise during the molecular diagnosis of SAIDs.
The pyrin inflammasome has evolved as an innate immune sensor to detect bacterial toxin-induced Rho guanosine triphosphatase (Rho GTPase)-inactivation, a process that is similar to the "guard" mechanism in plants. Rho GTPases act as molecular switches to regulate a variety of signal transduction pathways including cytoskeletal organization. Pathogens can modulate Rho GTPase activity to suppress host immune responses such as phagocytosis. Pyrin is encoded by MEFV, the gene that is mutated in patients with familial Mediterranean fever (FMF). FMF is the prototypic autoinflammatory disease characterized by recurring short episodes of systemic inflammation and is a common disorder in many populations in the Mediterranean basin. Pyrin specifically senses modifications in the activity of the small GTPase RhoA, which binds to many effector proteins including the serine/threonine-protein kinases PKN1 and PKN2 and actin-binding proteins. RhoA activation leads to PKN-mediated phosphorylation-dependent pyrin inhibition. Conversely, pathogen virulence factors downregulate RhoA activity in a variety of ways, and these changes are detected by the pyrin inflammasome irrespective of the type of modifications. MEFV pathogenic variants favor the active state of pyrin and elicit proinflammatory cytokine release and pyroptosis. They can be inherited either as a dominant or recessive trait depending on the variant's location and effect on the protein function. Mutations in the C-terminal B30.2 domain are usually considered recessive, although heterozygotes may manifest a biochemical or even a clinical phenotype. These variants are hypomorphic in regard to their effect on intramolecular interactions, but ultimately accentuate pyrin activity. Heterozygous mutations in other domains of pyrin affect residues critical for inhibition or protein oligomerization, and lead to constitutively active inflammasome. In healthy carriers of FMF mutations who have the subclinical inflammatory phenotype, the increased activity of pyrin might have been protective against endemic infections over human history. This finding is supported by the observation of high carrier frequencies of FMF-mutations in multiple populations. The pyrin inflammasome also plays a role in mediating inflammation in other autoinflammatory diseases linked to dysregulation in the actin polymerization pathway. Therefore, the assembly of the pyrin inflammasome is initiated in response to fluctuations in cytoplasmic homeostasis and perturbations in cytoskeletal dynamics.